Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1966]

Rare mutations in non small cell lung cancer

Dr Tom Stinchcombe - Duke Cancer Institute, Durham, USA

Rare mutations in non small cell lung cancer ( Dr Tom Stinchcombe - Duke Cancer Institute, Durham, USA )

The promise of immunotherapy in head and neck, and prostate cancer

Dr Luis Larrea - NISA, Valencia, Spain

The promise of immunotherapy in head and neck, and prostate cancer ( Dr Luis Larrea - NISA, Valencia, Spain )

Several important studies for lung cancer

Prof Luis Raez - Herbert Wertheim College of Medicine, Miami, USA

Several important studies for lung cancer ( Prof Luis Raez - Herbert Wertheim College of Medicine, Miami, USA )

Key advances in ALL and AML

Dr Martin S. Tallman - Moffitt Cancer Center, Tampa, USA

Key advances in ALL and AML ( Dr Martin S. Tallman - Moffitt Cancer Center, Tampa, USA )

Four studies about relapsed myeloma and advanced disease

Prof Melissa Alsina -Moffitt Cancer Center, Tampa, USA

Four studies about relapsed myeloma and advanced disease ( Prof Melissa Alsina -Moffitt Cancer Center, Tampa, USA )

The ICMC: a new path for microbiome research

Prof Julian Marchesi - Imperial College London, London, UK

The ICMC: a new path for microbiome research ( Prof Julian Marchesi - Imperial College London, London, UK )

The microbiome and cancer: cause or correlation?

Dr James Kinross - Imperial College London, London, UK

The microbiome and cancer: cause or correlation? ( Dr James Kinross - Imperial College London, London, UK )

항암화학요법으로 인한 호중구감소증과 G-CSF의 역할

마티 아프로 교수 - 제놀리어 암 센터, 스위스 제놀리어

항암화학요법으로 인한 호중구감소증과 G-CSF의 역할 ( 마티 아프로 교수 - 제놀리어 암 센터, 스위스 제놀리어 )

항암화학요법으로 인한 호중구감소증과 G-CSF의 역할

베르나르도 라포포트 교수 – 로스뱅크의 종양학 센터, 요하네스버그, 남아프리카 공화국

항암화학요법으로 인한 호중구감소증과 G-CSF의 역할 ( 베르나르도 라포포트 교수 – 로스뱅크의 종양학 센터, 요하네스버그, 남아프리카 공화국 )

Unexpected role for Immuno-oncology in SCCOHT

Dr Douglas Levine - NYU Langone Medical Center, New York, USA

Unexpected role for Immuno-oncology in SCCOHT ( Dr Douglas Levine - NYU Langone Medical Center, New York, USA )

Precision approaches for immunotherapy

Dr Eric H Rubin - Senior Vice President Global Clinical Development, Oncology...

Precision approaches for immunotherapy ( Dr Eric H Rubin - Senior Vice President Global Clinical Development, Oncology Early Development, MSD )

IG rearrangement, JAK1/2 inhibition and aggressive B-cell lymphoma development...

Prof Veronika Sexl - University of Veterinary Medicine of Vienna, Vienna...

IG rearrangement, JAK1/2 inhibition and aggressive B-cell lymphoma development... ( Prof Veronika Sexl - University of Veterinary Medicine of Vienna, Vienna, Austria )

More from ecancer